​
​

Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

OverviewChart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 0.03% institutional investors, and 99.97% retail investors. Voya investment management is the largest institutional shareholder, holding 0% of SELB shares.

SELB Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCartesian Therapeutics0.03%-99.97%
SectorHealthcare Stocks 47.31%8.01%44.69%
IndustryBiotech Stocks 45.43%7.81%46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Voya investment management---
Wny asset management---
Proshare advisors---
Prudential financial---
Legal & general group---
Renaissance---
Engineers gate manager lp---
Blackrock---
New york state common retirement fund---
Geode capital management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Voya investment management---
Wny asset management---
Proshare advisors---
Prudential financial---
Legal & general group---
Renaissance---
Engineers gate manager lp---
Blackrock---
New york state common retirement fund---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Fny investment advisers---100.00
Russell investments group---211.00
Group one trading---2.83K
Newbridge financial services group---3.00K
Amalgamated bank---3.92K

Top Sellers

HolderShares% AssetsChange
Fmr---14.37M
Artal group---9.14M
Blackrock---7.25M
Vanguard group---6.32M
Geode capital management---2.50M

Sold Out

HolderChange
Fny investment advisers-100.00
Russell investments group-211.00
Group one trading-2.83K
Newbridge financial services group-3.00K
Amalgamated bank-3.92K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202463-21.25%51,457,035-0.38%-2991.59%15-53.13%2931.82%
Dec 31, 202380-4.76%51,654,9330.44%-3025.30%3214.29%22-24.14%
Sep 30, 202384-6.67%51,430,059-5.01%-2721.78%28-44.00%2938.10%
Jun 30, 202390-3.23%54,141,38820.63%-4174.05%5011.11%21-16.00%
Mar 31, 2023939.41%44,882,986-16.18%-2429.57%4566.67%25-26.47%

Top Mutual Funds Shareholders

HolderShares% HoldingChange

Recent Insider Transactions

DateNameRoleActivityValue

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q41-
2023 Q3-2
2023 Q2--
2023 Q1-16

SELB Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 0.03%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 45.43%, which Cartesian Therapeutics falls below.

Who owns the most shares of Cartesian Therapeutics?

Cartesian Therapeutics’s largest shareholders are Voya investment management (0 shares, 0%), Wny asset management (0 shares, 0%), and Proshare advisors (0 shares, 0%). Together, they hold 0% of Cartesian Therapeutics’s total shares outstanding.

Does Blackrock own Cartesian Therapeutics?

Yes, BlackRock owns 0% of Cartesian Therapeutics, totaling 0 shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 0$. In the last quarter, BlackRock decreased its holdings by -7.254M shares, a -100.00% change.

Who is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested?

Voya investment management is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Cartesian Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools